Rabies virus glycoprotein 29 (RVG29) promotes CAR-T immunotherapy for glioma

van Tellingen, 2015, Overcoming the blood-brain tumor barrier for effective glioblastoma treatment, Drug Resist Update, 19, 1, 10.1016/j.drup.2015.02.002 Yao, 2018, Cellular origin of glioblastoma and its implication in precision therapy, Cell Mol Immunol, 15, 737, 10.1038/cmi.2017.159 Wong, 2021, A microfluidic cell-migration assay for the prediction of progression-free survival and recurrence time of patients with glioblastoma, Nat Biomed Eng, 5, 26, 10.1038/s41551-020-00621-9 Grupp, 2013, Chimeric antigen receptor-modified T cells for acute lymphoid leukemia, New Engl J Med, 368, 1509, 10.1056/NEJMoa1215134 Bielamowicz, 2018, Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma, Neuro-Oncology, 20, 506, 10.1093/neuonc/nox182 Hegde, 2019, Tandem CAR T cells targeting HER2 and IL13Ralpha2 mitigate tumor antigen escape, J Clin Invest, 129, 3464, 10.1172/JCI131246 Wang, 2020, Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma, Sci Transl Med, 12, 10.1126/scitranslmed.aaw2672 Gilham, 2012, CAR-T cells and solid tumors: tuning T cells to challenge an inveterate foe, Trends Mol Med, 18, 377, 10.1016/j.molmed.2012.04.009 Donovan, 2020, Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma, Nat Med, 26, 720, 10.1038/s41591-020-0827-2 Schaffenrath, 2021, Blood-brain barrier alterations in human brain tumors revealed by genome-wide transcriptomic profiling, Neuro-Oncology, 23, 2095, 10.1093/neuonc/noab022 Vivanco, 2012, Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors, Cancer Discov, 2, 458, 10.1158/2159-8290.CD-11-0284 Wadia, 2003, Modulation of cellular function by TAT mediated transduction of full-length proteins, Curr Protein Pept Sc, 4, 97, 10.2174/1389203033487289 Comoglu, 2017, Nanocarriers for effective brain drug delivery, Curr Top Med Chem, 17, 1490, 10.2174/1568026616666161222101355 Alam, 2010, Strategy for effective brain drug delivery, Eur J Pharm Sci, 40, 385, 10.1016/j.ejps.2010.05.003 Ja-Young, 2013, Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier, Biomaterials, 34, 1170, 10.1016/j.biomaterials.2012.09.047 Hua, 2018, RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy, Int J Pharm, 543, 179, 10.1016/j.ijpharm.2018.03.028 Linhao, 2018, Targeted brain delivery of rabies virus glycoprotein 29-modified deferoxamine-loaded nanoparticles reverses functional deficits in Parkinsonian mice, ACS Nano, 12, 4123, 10.1021/acsnano.7b08172 Liu, 2013, Targeting caspase-3 as dual therapeutic benefits by RNAi facilitating brain-targeted nanoparticles in a rat model of Parkinson's disease, PLoS One, 8, e62905, 10.1371/journal.pone.0062905 Yang, 2009, Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles, Biomaterials, 30, 4195, 10.1016/j.biomaterials.2009.02.051 Yang, 2014, Production and characterization of a fusion peptide derived from the rabies virus glycoprotein (RVG29), Protein Expres Purif, 104, 7, 10.1016/j.pep.2014.09.001 Cheng, 2012, Target delivery of a gene into the brain using the RVG29-oligoarginine peptide, Biomaterials, 33, 3456, 10.1016/j.biomaterials.2011.12.017 Han, 2021, Macrophage membrane-coated nanocarriers co-modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice, Bioact Mater, 6, 529, 10.1016/j.bioactmat.2020.08.017 Sauer, 2021, CD70-specific CAR T-cells have potent activity against acute myeloid leukemia (AML) without HSC toxicity, Blood, 138, 318, 10.1182/blood.2020008221 Deng, 2021, CD70-targeting CAR-T cells have potential activity against CD19-negative B-cell lymphoma, Cancer Commun, 41, 925, 10.1002/cac2.12201 Linchun, 2018, CD70, a novel target of CAR T-cell therapy for gliomas, Neuro-Oncology, 20, 55, 10.1093/neuonc/nox116 Ge, 2017, Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM, Int J Cancer, 141, 1434, 10.1002/ijc.30830 Feng, 2021, Targeting the DNA damage response enhances CD70 CAR-T cell therapy for renal carcinoma by activating the cGAS-STING pathway, J Hematol Oncol, 14, 152, 10.1186/s13045-021-01168-1 Smith Kyle, 2020, Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource, Acta Neuropathol, 140, 209, 10.1007/s00401-020-02171-5 Crowe, 2019, Semi-quantitative determination of protein expression using immunohistochemistry staining and analysis: an integrated protocol, Bio-Protocol, 9, e3465, 10.21769/BioProtoc.3465 Park Anthony, 2020, Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors, Sci Transl Med, 12, z1863, 10.1126/scitranslmed.aaz1863 Lu, 2020, An iRGD-conjugated prodrug micelle with blood-brain-barrier penetrability for anti-glioma therapy, Biomaterials, 230, 10.1016/j.biomaterials.2019.119666 Meijia, 2020, Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors, Theranostics, 10, 7622, 10.7150/thno.43991 Newman Aaron, 2019, Determining cell type abundance and expression from bulk tissues with digital cytometry, Nat Biotechnol, 37, 773, 10.1038/s41587-019-0114-2 Hwang, 2020, mRNA destabilization by BTG1 and BTG2 maintains T cell quiescence, Science, 367, 1255, 10.1126/science.aax0194 Lin, 2020, EGFR-targeted CAR-T cells are potent and specific in suppressing triple-negative breast cancer both in vitro and in vivo, Clin Transl Immunol, 9, e1135, 10.1002/cti2.1135 Ma, 2021, An oncolytic virus expressing IL15/IL15Ralpha combined with off-the-shelf EGFR-CAR NK cells targets glioblastoma, Cancer Res, 81, 3635, 10.1158/0008-5472.CAN-21-0035 Zhu, 2022, Enhancement of CD70-specific CAR T treatment by IFN-gamma released from oHSV-1-infected glioblastoma, Cancer Immunol Immun, 71, 2433, 10.1007/s00262-022-03172-x Han, 2015, CAR-engineered NK cells targeting wild-type EGFR and EGFRvIII enhance killing of glioblastoma and patient-derived glioblastoma stem cells, Sci Rep UK, 5, 11483, 10.1038/srep11483 Wei, 2022, Rabies virus glycoprotein-mediated transportation and T cell infiltration to brain tumor by magnetoelectric gold yarnballs, ACS Nano, 16, 4014, 10.1021/acsnano.1c09601 Sanfang, 2019, CD19 and CD70 dual-target chimeric antigen receptor t-cell therapy for the treatment of relapsed and refractory primary central nervous system diffuse large B-cell lymphoma, Front Oncol, 9, 1350, 10.3389/fonc.2019.01350 Fry, 2018, CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy, Nat Med, 24, 20, 10.1038/nm.4441 Liu, 2020, Split chimeric antigen receptor-modified T cells targeting glypican-3 suppress hepatocellular carcinoma growth with reduced cytokine release, Ther Adv Med Oncol, 12, 1, 10.1177/1758835920910347 Donovan Laura, 2020, Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma, Nat Med, 26, 720, 10.1038/s41591-020-0827-2 Wagner, 2020, CAR T cell therapy for solid tumors: bright future or dark reality?, Mol Ther, 28, 2320, 10.1016/j.ymthe.2020.09.015 Okada, 2019, Application of highly immunocompromised mice for the establishment of patient-derived xenograft (PDX) models, Cells Basel, 8, 889, 10.3390/cells8080889 Collins, 2018, A systematic review of the validity of patient derived xenograft (PDX) models: the implications for translational research and personalised medicine, Peer J, 6, e5981, 10.7717/peerj.5981 Julia, 2022, RASA2 ablation in T cells boosts antigen sensitivity and long-term function, Nature, 609, 174, 10.1038/s41586-022-05126-w Kishton, 2017, Metabolic regulation of T cell longevity and function in tumor immunotherapy, Cell Metab, 26, 94, 10.1016/j.cmet.2017.06.016 Obar, 2010, Memory CD8+ T cell differentiation, Ann NY Acad Sci, 1183, 251, 10.1111/j.1749-6632.2009.05126.x